LIPOPROTEIN(A) IN DIABETIC-PATIENTS AND NORMOGLYCEMIC RELATIVES IN FAMILIAL NIDDM

被引:47
|
作者
VELHO, G
ERLICH, D
TURPIN, E
NEEL, D
COHEN, D
FROGUEL, P
PASSA, P
机构
[1] HOSP ST LOUIS, DEPT ENDOCRINOL, PARIS, FRANCE
[2] HOSP ST LOUIS, BIOCHEM LAB, LIPIDS & PROT UNIT, PARIS, FRANCE
关键词
D O I
10.2337/diacare.16.5.742
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE - To compare lipoprotein(a) levels in diabetic patients and normoglycemic relatives in familial NIDDM and to assess whether Lp(a) is a risk factor for myocardial infarction in this population. RESEARCH DESIGN AND METHODS - We compared 577 patients and 261 normoglycemic relatives from 189 NIDDM multiplex families with 49 unrelated healthy individuals. Of the 577, 23 patients with previously documented myocardial infarction were further analyzed as a separate group. RESULTS - Lp(a) concentrations in diabetic patients, normoglycemic relatives, and the control group were not significantly different. Variance of Lp(a) in a given individual could not be accounted for by any clinical or biological parameter, but was strongly related to the mean Lp(a) value in his or her family. Diabetic patients with previous myocardial infarction (and their relatives) had significantly higher levels of Lp(a) than patients without coronary heart disease complaints. CONCLUSIONS - Lp(a) concentration in familial NIDDM was not related to the degree of glucose intolerance, but presented a strong familial aggregation. High Lp(a) levels seem to be an independent risk factor for myocardial infarction in this NIDDM cohort.
引用
收藏
页码:742 / 747
页数:6
相关论文
共 50 条
  • [1] LIPOPROTEIN ABNORMALITIES IN NORMOGLYCEMIC RELATIVES OF TYPE-2 DIABETIC-PATIENTS
    STEWART, MW
    WEBSTER, J
    MITCHESON, J
    HUMPHRISS, D
    BERRISH, T
    WALKER, M
    LAKER, MF
    DIABETOLOGIA, 1995, 38 : A249 - A249
  • [2] ARE LIPOPROTEIN (A) LEVELS INCREASED IN RELATIVES OF TYPE-2 DIABETIC-PATIENTS
    STEWART, MW
    HUMPHRISS, DB
    BERRISH, TS
    BARRIOCANAL, L
    TRAJANO, L
    WALKER, M
    DIABETOLOGIA, 1994, 37 : A145 - A145
  • [3] Lipoprotein(a) level and lipids in type 2 diabetic patients and their normoglycemic first-degree relatives in type 2 diabetic pedigrees
    Tian, HM
    Han, LC
    Ren, Y
    Li, XJ
    Liang, JZ
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2003, 59 (01) : 63 - 69
  • [4] HORMONE LEVELS AND INSULIN REQUIREMENTS IN PREGNANT NORMOGLYCEMIC DIABETIC-PATIENTS
    BARANYI, E
    TAMAS, G
    EGYED, J
    POTECZIN, E
    DIABETOLOGIA, 1982, 23 (02) : 153 - 153
  • [5] DYSLIPIDEMIAS AMONG NORMOGLYCEMIC MEMBERS OF FAMILIAL NIDDM PEDIGREES
    SCHUMACHER, MC
    MAXWELL, TM
    WU, LL
    HUNT, SC
    WILLIAMS, RR
    ELBEIN, SC
    DIABETES CARE, 1992, 15 (10) : 1285 - 1289
  • [6] SIMVASTATIN LOWERS LIPOPROTEIN(A) IN DIABETIC-PATIENTS
    OWENS, D
    DEEGAN, P
    GILLIGAN, S
    COLLINS, P
    JOHNSON, A
    TOMKIN, GH
    DIABETOLOGIA, 1994, 37 : A66 - A66
  • [7] ABNORMAL LIPOPROTEIN COMPOSITION IN NORMOLIPIDEMIC DIABETIC-PATIENTS
    IWAI, M
    YOSHINO, G
    MATSUSHITA, M
    MORITA, M
    MATSUBA, K
    KAZUMI, T
    BABA, S
    DIABETES CARE, 1990, 13 (07) : 792 - 796
  • [8] LIPOPROTEIN (A) AND VASCULAR-DISEASE IN DIABETIC-PATIENTS
    JAMES, RW
    BOEMI, M
    SIROLLA, C
    AMADIO, L
    FUMELLI, P
    POMETTA, D
    DIABETOLOGIA, 1995, 38 (06) : 711 - 714
  • [9] POLYENYLPHOSPHATIDYLCHOLINE IMPROVES THE LIPOPROTEIN PROFILE IN DIABETIC-PATIENTS
    KIRSTEN, R
    HEINTZ, B
    NELSON, K
    HESSE, K
    SCHNEIDER, E
    OREMEK, G
    NEMETH, N
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 1994, 32 (02) : 53 - 56
  • [10] Familial clustering of diabetic nephropathy in NIDDM patients.
    Canani, L
    Gerchman, F
    Gross, J
    DIABETES, 1997, 46 : 275 - 275